MedPath
NMPA Approval

Dobutamine Hydrochloride Injection

国药准字H20247162

July 12, 2024

国药准字H34021911

Drug Information

盐酸多巴酚丁胺注射液

注射剂

5ml∶100mg(按C₁₈H₂₃NO₃计)

化学药品

July 12, 2024

Company Information

Applicant Company

安徽省芜湖市高新技术产业开发区长江南路152号

Manufacturing Company

安徽省芜湖市高新技术产业开发区长江南路152号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸多巴酚丁胺注射液 - NMPA 批准文号 | MedPath